Dier Mardi
EVP and CFO · 30 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 646 | $431.94 | $279,033.24 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 420 | $426.86 | $179,282.80 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 160 | $434.20 | $69,472.00 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 160 | $429.00 | $68,639.20 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 120 | $430.90 | $51,708.40 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 116 | $432.56 | $50,176.48 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 80 | $436.69 | $34,935.20 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 80 | $435.32 | $34,825.20 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 80 | $427.85 | $34,227.60 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 40 | $437.65 | $17,506.00 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 40 | $429.58 | $17,183.20 | filing |
| 2026-03-06 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 40 | $425.08 | $17,003.20 | filing |
| 2026-03-04 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Award | 5,215 | $0.00 | $0.00 | filing |
| 2026-03-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,183 | $427.21 | $505,389.43 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Option exercise | 4,173 | $251.63 | $1.1M | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 717 | $574.00 | $411,558.79 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 480 | $579.85 | $278,329.20 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 410 | $571.99 | $234,515.57 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 354 | $573.02 | $202,847.35 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 320 | $577.81 | $184,900.61 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 320 | $570.39 | $182,523.52 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 258 | $578.83 | $149,338.40 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 240 | $587.85 | $141,083.88 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 240 | $585.44 | $140,505.19 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 240 | $576.15 | $138,276.41 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 160 | $590.37 | $94,459.60 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 160 | $589.65 | $94,343.66 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 120 | $574.95 | $68,994.29 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 80 | $596.19 | $47,694.80 | filing |
| 2025-12-02 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sale | 74 | $595.20 | $44,045.15 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.